The neuropsychopharmacology of cannabis:a review of human imaging studies

Autor: Matthew B. Wall, Sebastian F. Green, Katherine Petrilli, M Olabisi Ogunbiyi, Michael A P Bloomfield, Tom P. Freeman, Matthijs G. Bossong, Harry Costello, Rachel Lees, Chandni Hindocha
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
CBD
Cannabidiol

Marijuana Abuse
Cannabinoid receptor
MRI
Magnetic resonance imaging

medicine.medical_treatment
EEG
Electroencephalography

HIGH-POTENCY CANNABIS
Review
BOLD
Blood-oxygen-level dependent

PET
Positron emission tomography

0302 clinical medicine
Cognition
MAGNETIC-RESONANCE
Pharmacology (medical)
FREQUENT MARIJUANA USE
Pharmacology & Pharmacy
Dronabinol
Non-U.S. Gov't
biology
Research Support
Non-U.S. Gov't

Brain
FUNCTIONAL CONNECTIVITY
CBF
Cerebral blood flow

Neuropsychopharmacology
STRIATAL DOPAMINE RELEASE
MRS
Magnetic resonance spectroscopy

SPATIAL WORKING-MEMORY
OFC
Orbitofrontal cortex

030220 oncology & carcinogenesis
PFC
Prefrontal cortex

CT
Computed tomography

DLPFC
Dorsolateral prefrontal cortex

ASL
Arterial spin labelling

1115 Pharmacology and Pharmaceutical Sciences
THC
Δ9-Tetrahydrocannabinol

MID
Monetary incentive delay

Life Sciences & Biomedicine
medicine.drug
FDG
Fludeoxyglucose

Diagnostic Imaging
medicine.medical_specialty
EARLY-ONSET SCHIZOPHRENIA
Human Development
DTI
Diffusion tensor imaging

Addiction
Neuroimaging
Development
Research Support
Article
NAA
N-Acetylaspartate

03 medical and health sciences
D2R
Dopamine type 2 receptor

fMRI
Functional magnetic resonance imaging

medicine
Journal Article
GABA
γ-Aminobutyric acid

Animals
Humans
Psychiatry
Tetrahydrocannabinol
Effects of cannabis
Cannabis
Pharmacology
Psychotropic Drugs
Science & Technology
PCC
Posterior cingulate cortex

business.industry
Psychoactive drug
D-2/D-3 RECEPTOR AVAILABILITY
biology.organism_classification
Psychosis
030104 developmental biology
NAc
Nucleus accumbens

ANTERIOR CINGULATE CORTEX
CEREBRAL-BLOOD-FLOW
Cannabinoid
ACC
Anterior cingulate cortex

business
Cannabidiol
CB1R
Endocannabinoid type 1 receptor
Zdroj: Bloomfield, M A P, Hindocha, C, Green, S F, Wall, M B, Lees, R, Petrilli, K, Costello, H, Olabisi Ogunbiyi, M, Bossong, M G & Freeman, T P 2018, ' The neuropsychopharmacology of cannabis : a review of human imaging studies ', Pharmacology and Therapeutics . https://doi.org/10.1016/j.pharmthera.2018.10.006
Pharmacology & Therapeutics
Pharmacology & Therapeutics, 195, 132. Elsevier Inc.
Bloomfield, M A P, Hindocha, C, Green, S F, Wall, M B, Lees, R, Petrilli, K, Costello, H, Olabisi Ogunbiyi, M, Bossong, M G & Freeman, T P 2018, ' The neuropsychopharmacology of cannabis: a review of human imaging studies ', Pharmacology and Therapeutics . https://doi.org/10.1016/j.pharmthera.2018.10.006
ISSN: 0163-7258
DOI: 10.1016/j.pharmthera.2018.10.006
Popis: The laws governing cannabis are evolving worldwide and associated with changing patterns of use. The main psychoactive drug in cannabis is Δ9-tetrahydrocannabinol (THC), a partial agonist at the endocannabinoid CB1 receptor. Acutely, cannabis and THC produce a range of effects on several neurocognitive and pharmacological systems. These include effects on executive, emotional, reward and memory processing via direct interactions with the endocannabinoid system and indirect effects on the glutamatergic, GABAergic and dopaminergic systems. Cannabidiol, a non-intoxicating cannabinoid found in some forms of cannabis, may offset some of these acute effects. Heavy repeated cannabis use, particularly during adolescence, has been associated with adverse effects on these systems, which increase the risk of mental illnesses including addiction and psychosis. Here, we provide a comprehensive state of the art review on the acute and chronic neuropsychopharmacology of cannabis by synthesizing the available neuroimaging research in humans. We describe the effects of drug exposure during development, implications for understanding psychosis and cannabis use disorder, and methodological considerations. Greater understanding of the precise mechanisms underlying the effects of cannabis may also give rise to new treatment targets.
Databáze: OpenAIRE